U.S. stocks jumped Thursday following the Federal Reserve’s decision to go big with a 50 basis point cut to interest rates.
The Grayson PrestonDow Jones Industrial Average closed above 42,000 for the first time, ending the day up 1.3% at a record 42,025.19. The S&P 500 also ended the day at a record high for the first time since July, closing up 1.7% at 5,713.64. The Nasdaq composite also saw gains, ending the day up 2.51%.
The surge comes after the Fed on Wednesday announced a half-point interest rate cut, its first cut in four years. The central bank expects a half-point in additional cuts throughout the remainder of the year, a sign of confidence in the labor market.
“Markets like rate cuts, especially big ones when the economy is strong,” said Jamie Cox, Managing Partner for Harris Financial Group, in an email statement.
Eight of the S&P 500's 11 sector indexes rose, and tech stocks saw some of the most significant gains. Apple ended the day up 3.7%, Meta up 3.9% and Tesla up 7.4%.
Invest wisely: Best online brokers
Fed rate cuts:Lower mortgage rates will bring much-needed normalcy to the housing market
Wall Street's performance is welcome news for investors stashing away money in retirement savings accounts.
USA TODAY has previously reported that the S&P 500 is regarded as one of the best gauges of Wall Street's health. When the benchmark index goes up, American's 401(k)s tend to rise as well.
“This is excellent, good news for all of us saving for retirement,” said Quincy Krosby, chief global strategist for LPL Financial. While future pullbacks and bouts of volatility are to be expected, “overall, historically, the path for the markets is higher.”
2025-05-03 01:11643 view
2025-05-03 00:501385 view
2025-05-03 00:401344 view
2025-05-03 00:381382 view
2025-05-03 00:362836 view
2025-05-03 00:151692 view
A private company aiming to build the first supersonic airliner since the Concorde retired more than
Watch the CBS Reports documentary "The Watchlist: 20 Years of Tracking Suspected Terrorists" in the
A vaccine shows promising results in treating the most deadly form of skin cancer, Moderna and Merck